Nrf2 deficiency increases oligodendrocyte loss, demyelination, neuroinflammation and axonal damage in an MS animal...

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Oxidative stress is central to central nervous system (CNS) diseases like multiple sclerosis (MS).
• The nuclear factor E2-related factor 2 (Nrf2) pathway, particularly in astrocytes, shows promise in mitigating MS pathology.
• Dimethylfumarate, an Nrf2 activator, is an approved MS therapeutic.

Purpose of the Study:

• To investigate the role of Nrf2 in the cuprizone mouse model of MS.
• To assess the impact of Nrf2 deficiency on oxidative stress, oligodendrocyte loss, neuroinflammation, and axonal damage.

Main Methods:

• Utilized the cuprizone mouse model to induce MS-like pathology.
• Compared wild-type and Nrf2-deficient mice under cuprizone challenge.
• Assessed oligodendrocyte apoptosis, neuroinflammation markers, and axonal damage.

Main Results:

• Nrf2-deficient mice exhibited exacerbated oligodendrocyte apoptosis and loss compared to wild-type controls.
• Neuroinflammation and axonal damage were significantly higher in Nrf2-deficient mice.
• Nrf2-deficient mice showed increased susceptibility to cuprizone in the commissura anterior white matter tract.

Conclusions:

• Nrf2 plays a critical protective role against oxidative stress and MS-like pathology in the CNS.
• The cuprizone model is valuable for studying the interactions between oxidative stress, neuroinflammation, and axonal damage in MS.
• Further research is needed to explore Nrf2 expression patterns and variable susceptibility to cuprizone.